Introduction: Arytenoid cartilage ossification (AO) may be a benign phenomenon, but may also occur in response to neoplastic or inflammatory stimuli. While AO has been studied in the context of advanced laryngeal cancer, its clinical significance in early glottic carcinoma (EGC) remains unclear. This study aims to evaluate the prevalence of AO in EGC, its association with tumor stage and treatment outcomes. Methods: A retrospective, two-center study was conducted on 25 male patients diagnosed with EGC (carcinoma in situ, stages I and II) between 2005 and 2019. All patients underwent pre-treatment contrast-enhanced computed tomography (CT) scans, which were independently reviewed by a blinded neuroradiologist to assess AO pattern (none, circumferential, or complete). Clinical data, tumor characteristics, and treatment outcomes were extracted from medical records. Statistical analyses were performed to explore associations between AO, tumor stage, and treatment outcome. Results: AO was present in 56% (14/25) of patients, with equal distribution between complete and circumferential types. AO was significantly more frequent on the tumor-involved side thank on the tumor-free side (50% vs. 10%, p=0.005). Complete AO was observed predominantly in stage II tumors (6/7 cases), and AO overall was significantly more prevalent in stage II than in stage I or carcinoma in situ (p=0.045). No statistically significant association was found between AO and treatment outcome. Conclusion: AO is a common radiologic finding in EGC, particularly in patients with stage II disease, where complete ossification is more frequently observed. While AO is associated with tumor stage, it does not appear to predict treatment outcome.